Monday after Epiphany Reading I 1 Jn 3:22–4:6

New Post Public Reply Private Reply Replies (0) Message Board
Bible Feed
311
Monday after Epiphany

Reading I 1 Jn 3:22–4:6

Beloved: We receive from him whatever we ask, because we keep his commandments and do what pleases him. And his commandment is this: we should believe in the name of his Son, Jesus Christ, and love one another just as he commanded us. Those who keep his commandments remain in him, and he in them, and the way we know that he remains in us is from the Spirit whom he gave us. Beloved, do not trust every spirit but test the spirits to see whether they belong to God, because many false prophets have gone out into the world. This is how you can know the Spirit of God: every spirit that acknowledges Jesus Christ come in the flesh belongs to God, and every spirit that does not acknowledge Jesus does not belong to God. This is the spirit of the antichrist who, as you heard, is to come, but in fact is already in the world. You belong to God, children, and you have conquered them, for the one who is in you is greater than the one who is in the world. They belong to the world; accordingly, their teaching belongs to the world, and the world listens to them. We belong to God, and anyone who knows God listens to us, while anyone who does not belong to God refuses to hear us. This is how we know the spirit of truth and the spirit of deceit.

Responsorial Psalm 2:7bc-8, 10-12a

R.        (8ab)   I will give you all the nations for an inheritance. The LORD said to me, “You are my Son;             this day I have begotten you. Ask of me and I will give you             the nations for an inheritance             and the ends of the earth for your possession.” R.         I will give you all the nations for an inheritance. And now, O kings, give heed;             take warning, you rulers of the earth. Serve the LORD with fear, and rejoice before him;             with trembling rejoice. R.         I will give you all the nations for an inheritance.

Alleluia See Mt 4:23

R.  Alleluia, alleluia. Jesus proclaimed the Gospel of the Kingdom and cured every disease among the people. R.  Alleluia, alleluia.

Gospel Mt 4:12-17, 23-25

When Jesus heard that John had been arrested, he withdrew to Galilee.  He left Nazareth and went to live in Capernaum by the sea, in the region of Zebulun and Naphtali, that what had been said through Isaiah the prophet  might be fulfilled: Land of Zebulun and land of Naphtali, the way to the sea, beyond the Jordan, Galilee of the Gentiles, the people who sit in darkness have seen a great light, on those dwelling in a land overshadowed by death light has arisen. From that time on, Jesus began to preach and say, “Repent, for the Kingdom of heaven is at hand.” He went around all of Galilee, teaching in their synagogues, proclaiming the Gospel of the Kingdom, and curing every disease and illness among the people.  His fame spread to all of Syria, and they brought to him all who were sick with various diseases and racked with pain, those who were possessed, lunatics, and paralytics, and he cured them.  And great crowds from Galilee, the Decapolis, Jerusalem, and Judea, and from beyond the Jordan followed him.  

- - -

Lectionary for Mass for Use in the Dioceses of the United States, second typical edition, Copyright © 2001, 1998, 1997, 1986, 1970 Confraternity of Christian Doctrine; Psalm refrain © 1968, 1981, 1997, International Committee on English in the Liturgy, Inc. All rights reserved. Neither this work nor any part of it may be reproduced, distributed, performed or displayed in any medium, including electronic or digital, without permission in writing from the copyright owner.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lear Capital Hits $5 Billion Milestone: Trust or Hype?

Updated Category News Views 0

A Golden Milestone or Just Glitter? Lear Capital's announcement of surpassing $5 billion in precious metals transactions feels like one of those moments where you tilt your head and ask, "Is it really what it seems?" With nearly 150,000 customers and almost three decades of hustling in the glittering world of gold and silver, they've certainly carved out a name in the...

Continue Reading
Infosys Transforms Syngenta's Tech Core to Boost Agility

Updated Category News Views 33

Unpacking the Syngenta-Infosys Transformation Forget your run-of-the-mill tech upgrade; Infosys has just spearheaded a massive transformation for Syngenta, delivering a new global SAP S/4HANA setup that’s set to turbocharge their Crop Protection business. We’re talking about more than just another software upgrade here—this is a sweeping overhaul affecting 10,000...

Continue Reading
Switchgear Monitoring Market Surges to $3.80 Billion

Updated Category News Views 71

Switchgear Monitoring: A Crucial Component in Modern Power Grids When the chips are down, it's the grid that keeps the lights on. Now, looks like switchgear monitoring systems are riding high on this global necessity. Fueled by infrastructure upgrades, the market's slated to leap from $2.36 billion in 2026 to a whopping $3.80 billion by 2031, clocking a solid 10.1% CAGR....

Continue Reading
Investors Shaken by Better Home’s 28.5% Plunge

Updated Category News Views 15

Pull up a chair, because Better Home & Finance Holding Company (NASDAQ: BETR) just threw its investors into a frenzy. Mayhem hit when their stock nosedived 28.5% on a single day—May 7, 2026. Let’s untangle what happened and why every shareholder should circle November 20 on their calendar. Unpacking the Fall: A Dive Into Hard Truths So, between mid-March and early May...

Continue Reading
Grünenthal Pushes Pain Boundaries with RISE Trial Win

Updated Category News Views 10

Grünenthal, coming straight outta Germany, is lighting up the stage at the 2026 IASP World Congress on Pain in Bangkok with some heavy-duty results from their Phase III RISE trial. We’re talking serious news for folks grappling with post-surgical neuropathic pain. Breaking Down the RISE Results Let’s cut to the chase: Qutenza®, the protagonist here, smashed through...

Continue Reading
NJ's $21.3M Water Fix Fights PFAS, Boosts AWK

Updated Category News Views 0

Water Woes Culminate in Triumph Alright, folks, you don't often see New Jersey in the headlines for anything groundbreaking in the right way, but here we are. The big news is a hefty $21.3 million project completion that finally puts some ammo against the notorious PFAS chemicals. If you've got any skin in the utility game or just a stake in clean water, this one's been...

Continue Reading
Centerspace Sale Faces Scrutiny Amid Investor Concerns

Updated Category News Views 85

Potential Undervaluation Looms Large over Centerspace Sale On a crisp October day, the saga of Centerspace's proposed sale to Independence Realty Trust (NYSE: IRT) is stirring the pot. Charles C. Foti, Jr., Esq., and the law firm Kahn Swick & Foti, LLC are throwing a wrench into the works, questioning the soundness of the whole shebang. The deal, valued at 3.800 shares of...

Continue Reading
Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Updated Category News Views 141

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Continue Reading
IBSSC 2026: A New Chapter in Business Education

Updated Category News Views 70

Shifts in Business Education at the IBSSC 2026 Boy, oh boy, Shanghai was buzzing the other week. We’re diving into the heart of the 11th International Business School Shanghai Conference (IBSSC). There's a changing of the guard in how business education is viewed, and it was all happening from October 21 to 23 at the Xuhui campus of Shanghai Jiao Tong University. Global...

Continue Reading
Navigating Market Uncertainty with Financial Planning

Updated Category News Views 14

Staying Calm Amid Market Chaos The market's like a roller coaster more often than not, and when headlines scream panic, even the most seasoned of us can begin to doubt our strategies. Jennifer Prosise from The Voyager Group, Ltd., in Joliet, IL, calls out this high-stakes game in HelloNation, emphasizing how financial planning serves as our anchor in the stormy seas of...

Continue Reading

Top 5 Most Recently Viewed Articles

Microbot Medical Secures Grant to Boost Manufacturing Strength

Updated Category News Views 146

Microbot Medical's Strategic Grant Acquisition Microbot Medical Inc., a pioneering medical technology firm, has made headlines with its recent achievement of securing a non-dilutive grant from the Israel Innovation Authority. This funding, amounting to roughly NIS 2.15 million (around $630,000), is poised to significantly enhance the operational capabilities of the...

Continue Reading
Stellantis Issues Recall for 33,777 Ram 1500 Vehicles Due to Safety Concerns

Updated Category News Views 231

Stellantis Recalls Ram 1500 Vehicles for Safety Issues Chrysler parent Stellantis NV is taking proactive measures to ensure consumer safety by recalling 33,777 Ram 1500 vehicles in the United States, according to the National Highway Traffic Safety Administration (NHTSA). Details of the Recalls This recall specifically targets model year 2025 Ram 1500 vehicles where there...

Continue Reading
Navigating Market Volatility: Nasdaq and S&P 500 Face Tests

Updated Category News Views 152

Understanding Current Market Dynamics US stock futures have taken a step back as traders embrace a more cautious approach, particularly in light of the upcoming jobs data release. The excitement surrounding this information is palpable, with market participants bracing themselves for potential surprises that could ignite volatility in the financial markets. As of now,...

Continue Reading
Sage Therapeutics Investors Urged to Join Securities Class Action

Updated Category News Views 204

Invitation to Join Securities Class Action Against Sage Therapeutics Investors who have experienced significant losses in their investments with Sage Therapeutics, Inc. (NASDAQ: SAGE) have a unique opportunity to take action. The Law Offices of Howard G. Smith is currently seeking investors to lead a class action lawsuit concerning potential securities fraud involving the...

Continue Reading
Andes Technology Unveils Powerful AndesCore™ AX66 Processor

Updated Category News Views 165

Introducing the AndesCore™ AX66 Processor In the fast-paced world of technology, continuous innovation is key. One company leading this charge is Andes Technology, known for its efficiency and cutting-edge RISC-V processor cores. Their latest announcement heralds the arrival of the AndesCore™ AX66, designed to support the RVA23 profile and bring significant...

Continue Reading